Home > Back to Publisher > Report Information

Access to Hospital Pharmaceutical Markets in the United Kingdom

JustPharmaReports.com
August 1, 2008
81 Pages - SKU: JPM1873428

Abstract Table of Contents Search inside this report Related Reports

Countries covered: United Kingdom

Public hospitals represent a very important market segment for most biopharmaceutical companies in Europe. They are the often the only market for the increasing numbers of speciality drugs emerging from R&D, with many primary care products also unable to get established for maintenance therapy in the community without hospital recommendation first. Though the processes for achieving hospital usage are very different to the reimbursed GP/community pharmacy sector, they have been poorly documented and often little understood. This justpharmareports’ publication aims to clarify the situation for the UK, a particularly challenging country with four different public healthcare systems, numerous stakeholders, regular reforms, and rigorous health technology assessment.

Medicines prescribed in English hospitals in 2006 were valued at £2.7 billion (€3.4 billion). This represented 24% of the English NHS drugs bill (hospital prescribing in London alone accounted for 40% of all prescribing costs in the capital). Even more significantly, the hospital drug bill has been rising at more than twice the rate of GP prescribing costs.

‘Access to Hospital Pharmaceutical Markets in the UK’ provides:

Comprehensive and clear information on how medicines for hospital use get selected, purchased, distributed, prescribed, dispensed and paid for.
Separate sections on England, Scotland, Wales and Northern Ireland.
Full coverage of the NHS plus two of the largest private providers.
Explanation of tendering, contracting, contract adjudication and other aspects of procurement for both brands and generics.
Clarification of the DRG-type funding system, Payment by Results.
Special focus on oncology.
What discounts hospitals expect and why value-added tax is a concern.
Features on risk-sharing schemes and on the boom in homecare services.
NICE, SMC, AWMSG, the PPRS and much, much more……………..

Executive Summary
1. Market Background: 1.1 UK; 1.2 National Health Service; 1.3 NHS Funding; 1.4 Pharmaceutical Use; 1.5 Strategic Implications
2. Managed Entry of New Drugs: 2.1 Horizon Scanning; 2.2 Formularies; 2.3 Health Technology Assessment; 2.4 Strategic Implications
3. Procurement: 3.1 Product Differentiation; 3.2 Procurement in England; 3.3 Procurement in Scotland; 3.4 Procurement in Wales; 3.5 Procurement in Northern Ireland; 3.6 Strategic Implications
4. Product Selection: 4.1 Price; 4.2 Non Price Criteria; 4.3 Parallel Imports; 4.4 Unlicensed Medicines; 4.5 Strategic Implications
5. Funding: 5.1 England: Payment by Results; 5.2 Other Countries; 5.3 Risk Sharing/Discounting Schemes

More United Kingdom Reports

A Comprehensive Study Of The UK Video Conferencing Equipment Market In 2010, Rating & Valuing Each Of The 30 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Tableware Market In 2010, Rating & Valuing Each Of The 166 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Surveyors & Valuers Market In 2010, Rating & Valuing Each Of The 943 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Subsea Engineering Market In 2010, Rating & Valuing Each Of The 142 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Structural Engineering Consultancy Market In 2010, Rating & Valuing Each Of The 300 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

See all reports like this >>

Access to Hospital Pharmaceutical Markets in the United Kingdom

Share this report

Other tasks

Research Assistance

Related Markets

Biopharmaceuticals Reports

Free Alert Me service